OpenADMET
  • Home
Sign in Subscribe
All Blind Challenges Models Data Infrastructure
Blind Challenges · January 27, 2026

The OpenADMET - ExpansionRx Blind Challenge has Come to an End

The OpenADMET - ExpansionRx Blind Challenge has Come to an End

Authors: Maria Castellanos, Hugo MacDermott-Opeskin DOI: 10.5281/zenodo.21784497 Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties can make or break the preclinical

Read More
Blind Challenges · December 2, 2025

OpenADMET - ExpansionRx Blind Challenge Intermediate Leaderboard

OpenADMET - ExpansionRx Blind Challenge Intermediate Leaderboard

Intermediate leaderboard release Authors: Maria Castellanos, Hugo MacDermott-Opeskin DOI: 10.5281/zenodo.21784394. Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties can make or

Read More
Blind Challenges · October 14, 2025

Announcement 2: ExpansionRx - OpenADMET Blind Challenge

Announcement 2: ExpansionRx - OpenADMET Blind Challenge

Authors: Hugo MacDermott-Opeskin, Maria Castellanos DOI: 10.5281/zenodo.21784247 Additional details on the coming challenge Absorption, Distribution, Metabolism, Excretion and Toxicity–ADMET–properties

Read More
Blind Challenges · September 16, 2025

Announcement 1: ExpansionRx-OpenADMET Blind Challenge

Announcement 1: ExpansionRx-OpenADMET Blind Challenge

Authors: Hugo MacDermott-Opeskin, Maria Castellanos DOI:10.5281/zenodo.21784074 Small molecules continue to be the bricks and mortar of drug discovery globally, accounting

Read More
← Newer Posts Page 2 of 2
OpenADMET

© 2026 OpenADMET · Content licensed CC BY 4.0